DECENTRALIZED MEDIA IS LIVE POWERED BY
Banx Media Platform logo
HEALTHMedical Tech

From Croatia to Japan, GlycanAge and ExoEarth Build a New Bridge Between Biomarkers and Longevity

Croatian-founded GlycanAge and Japan’s ExoEarth entered a strategic partnership to expand biological-age testing in Japan and pursue joint longevity research.

Y
Yamma VerixINTERMEDIATE
2 min read
3 Views
From Croatia to Japan, GlycanAge and ExoEarth Build a New Bridge Between Biomarkers and Longevity

Aging is measured in years, but modern biomedical research increasingly looks for other ways to understand what happens inside the body as those years pass. Among those approaches are biomarkers that attempt to provide measurable information about biological processes associated with aging.

A new international partnership is bringing one such technology closer to the Japanese market. UK-based, Croatian-founded biotechnology company GlycanAge has entered a strategic partnership with Japan’s ExoEarth, according to SeeNews and company announcements released in September.

The partnership is intended to expand access to GlycanAge’s biological-age testing in Japan while also creating opportunities for collaborative research related to longevity. ExoEarth said the cooperation is based on a memorandum of understanding between the two companies.

GlycanAge focuses on glycan biomarkers. Its platform analyzes glycosylation patterns attached to immunoglobulin G, or IgG, in blood. The company describes the measurement as an indicator related to immune aging and chronic inflammation rather than as a diagnostic test for a specific disease.

That distinction is important. A biological-age measurement is not the same thing as a conventional medical diagnosis. Instead, it is intended to provide another type of information that can be studied alongside other health measurements and lifestyle data.

ExoEarth’s interest extends beyond testing alone. The Japanese company said it plans to connect GlycanAge measurements with extracellular-vesicle research, continuing health and lifestyle data, artificial intelligence and other technologies as part of its broader longevity platform.

The partnership therefore brings together several areas of biotechnology. Glycan research focuses on molecular patterns, while extracellular-vesicle research examines biological particles involved in communication between cells. Artificial intelligence can provide another layer for organizing and analyzing large quantities of biological information.

Japan provides a significant potential market for such technologies because the country has long been associated with research and commercial activity surrounding healthy aging and longevity. ExoEarth has positioned the partnership within its broader effort to develop what it calls a personalized longevity platform.

GlycanAge also has an international research background. The company says its scientific foundation includes more than three decades of glycan research and collaborations involving universities and research institutions. Its platform has been studied in connection with biological aging, immune regulation and chronic inflammation.

The partnership does not by itself establish new medical benefits or guarantee particular health outcomes. Instead, it creates a framework for expanding testing access and conducting further research in Japan.

From Croatia’s entrepreneurial roots to biotechnology operations in the United Kingdom and research ambitions in Japan, the agreement reflects the increasingly international character of longevity science. The next stage will depend on research, validation and how these biological measurements can be integrated responsibly with other forms of health data.

Image Disclaimer:

Visuals are AI-generated conceptual representations of biotechnology research and the GlycanAge–ExoEarth partnership; they are not photographs of actual research procedures.

Published by Banx Network. This article is part of the Banx decentralized media programme, powered by the BXE token on the XRP Ledger.

Y
Written by
Yamma VerixINTERMEDIATE

A seasoned storyteller with years of experience crafting articles on culture, technology, and global affairs. Focused on delivering thoughtful, well-researched pieces with a distinctive editorial voice.

View Author Profile & Articles
Decentralized Media

Powered by the XRP Ledger & BXE Token

This article is part of the XRP Ledger decentralized media ecosystem. Become an author, publish original content, and earn rewards through the BXE token.

Newsletter

Stay ahead of the news — and win free BXE every week

Subscribe for the latest news headlines and get automatically entered into our weekly BXE token giveaway.

No spam. Unsubscribe anytime.

Share this story

Help others stay informed about crypto news

Related articles

Keep exploring the latest stories.

View more
Four Injured, One Critical After Stolen Car Crash in East Brisbane

Four Injured, One Critical After Stolen Car Crash in East Brisbane

A serious crash in East Brisbane involving a suspected stolen car left one person critical and 1,200 homes without power. Witnesses urged to come forward.

Lithuania Enacts Ban on Nonalcoholic Drinks Sales to Minors

Lithuania Enacts Ban on Nonalcoholic Drinks Sales to Minors

Lithuania's parliament has approved a ban on the sale of nonalcoholic drinks to minors, effective May 2027, amid concerns over normalizing alcohol consumption.

New Study Reveals Coffee's Impact on Gut Health and Function

New Study Reveals Coffee's Impact on Gut Health and Function

A recent study from the University of Copenhagen explores how coffee consumption affects gut bacteria and digestive function, revealing significant health impl…